Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 11.812\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CCOC(=O)Cc1csc(SCC(=O)N(CC(C)C)c2c(N)n(Cc3ccccc3)c(=O)[nH]c2=O)n1
b.) COc1ccc(Cl)cc1NC(=O)CCNS(=O)(=O)c1cccc2nonc12
Answer: b. COc1ccc(Cl)cc1NC(=O)CCNS(=O)(=O)c1cccc2nonc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Cl)cc1NC(=O)CCNS(=O)(=O)c1cccc2nonc12
COc1ccc(Cl)cc1NC(=O)CCNS(=O)(=O)c1cccc2nonc12
3-(2,1,3-benzoxadiazol-4-ylsulfonylamino)-N-(5-chloro-2-methoxyphenyl)propanamide